Articles On Global Health (ASX:GLH)

Title Source Codes Date
Weed Week: A VAST majority of Americans now want marijuana to be legal

Where are we in terms of US legalisation of cannabis? What about the current legal landscape for cannabis in Australia? We look at the best performing ASX weed stocks this past month   Global weed stocks have been on bumpy ride over the p...

Stockhead GLH 1 day ago
Melodiol welcomes Chuck’s petition to pass US SAFER Banking Act

US Majority Leader Chuck Schumer is urging people to endorse SAFER Banking Act by signing petition Act aims to enhance access to traditional financial services for cannabis companies in the US Melodiol Global Health could benefit as one of...

Stockhead GLH 1 week ago
Melodiol’s Mernova gains more traction in Canada: revenues increase, new products launched

Special Report: Melodiol Global’s subsidiary Mernova continues to gain traction in Canada as the company launches new cannabis products across various markets. Melodiol Global Health Limited (ASX:ME1)’s wholly-owned Canadian subsidiary, Mer...

Stockhead GLH 2 weeks ago
Top 10 at 11: High grade silica lights a small caps fire as miners make moves this morning

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead GLH 3 weeks ago
Closing Bell: ASX rebounds as soft CPI bolsters August rate cut hopes; OSX and TLM lead today’s winners

The ASX 200 erases early morning’s losses, rallying to close the day +0.3% higher.  This comes as the ABS released its monthly CPI report, which shows that YoY inflation was steady in February at 3.4% for a third straight month. The figure...

Stockhead GLH 3 weeks ago
Melodiol subsidiaries contribute $3.1 million revenue in first two months of 2024

Melodiol Global Health reports total unaudited revenue of $3.1 million in first two months of FY24 Recreational cannabis subsidiary Mernova Medicinal contributes $1.45 million driven by Ritual branded products ME1 recently reported total...

Stockhead GLH 3 weeks ago
Top 10 at 11: Little diggers turn up value as lithium, gold finds continue

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead GLH 3 weeks ago
New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World

Hub will focus on supporting global use of new treatments that effectively treated drug-resistant TB in 98% of Filipino participants MANILA, Australia, March 25, 2024 /PRNewswire/ — TB Alliance’s new Peer-to-Peer Learning for Innovative Cu...

FNArena GLH 3 weeks ago
Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB

AUD 17 Million Grant over 5 Years Will Fund Next-Generation TB Cures CANBERRA, Australia, March 25, 2024 /PRNewswire/ — The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million...

FNArena GLH 3 weeks ago
ASX February winners: The best 50 stocks as a ‘super-heroic small cap’ soars 322%

S&P/ASX 200 rose 0.8% in February with Large Cap S&P/ASX 50 underperforming Midcap and Small Ordinaries Tech sector was the big winner up 19% in February as energy and materials sector slumped  Nyrada soars after preclinical study...

Stockhead GLH 1 month ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead GLH 1 month ago
Recce Pharmaceuticals leads the way in collaborative Anti-Infective research

Recce Pharmaceuticals (ASX:RCE) highlights ongoing initiatives within its Anti-Infective Research (AIR) Unit situated at the Murdoch Children’s Research Institute (MCRI), Victoria The collaboration has been crucial in delivering positive...

themarketonline.com.au GLH 1 month ago
Closing Bell: Commodity prices, resurgent rate fears drag ASX to third straight loss

  ASX200 drops about 0.7pc on Wednesday Consumer Staples craters, as WOW CEO departs Small Caps led by diggers IXR, AW1 and the biopharma Alterity   The ASX200 has ended lower on Wednesday, tracking losses in New York as traders brace – a...

Stockhead GLH 1 month ago
Closing Bell: Local markets ride commodities higher after a blow to US confidence on Friday

  Local markets ride commodities lift to offset weak performance from Wall Street on Friday ASX 200 benchmark finished the day on +0.09pc, a lot higher than it really had any right to Resources led the way, overcoming a significant deadwei...

Stockhead GLH 1 month ago
Melodiol subsidiary Mernova expands products in six lucrative Canadian provinces

  Melodiol subsidiary Mernova Medicinal continues to grow as a dominant player in lucrative Canadian cannabis market Product range expands into six Canadian provinces Further cost optimisation initiatives to remove $400k from Mernova annua...

Stockhead GLH 2 months ago
Closing Bell: Blood plasma giant CSL bleeds out in front of entire ASX on Monday

  ASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small cap winners led by American Rare Earths and Appen   The benchmark was shot through the heart by CSL this morning leaving everything else in...

Stockhead GLH 2 months ago
Melodiol enjoys milestone 2023 as subsidiaries bank profits

  Melodiol Global Health says 2023 been a milestone year with strong growth across portfolio Melodiol delivering on strategy to bring core operating subsidiaries into profitability Company says its strategic priority continues to be gener...

Stockhead GLH 4 months ago
10 at 11ish: Aurumin to sell iron rights to Mineral Resources

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead GLH 4 months ago
Top 10 at 11: Major gains for sustainable ag after Roots flies a shipment out of Israel

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead GLH 4 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead GLH 5 months ago
In Case You Missed It: Firebrick back after review points to ‘inaccuracies in trial efficacy data’

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today. ICYMI Leaderb...

Stockhead GLH 5 months ago
Melodiol subsidiary HHI Australia delivers $1 million revenue in October

Melodiol subsidiary Health House International Australia delivers ~$1 million in revenue for October  Strong October performance continues progress from Q3 revenue of ~$3 million 12 month sales are ~$14 million, with EBITDA margin 12.7%...

Stockhead GLH 5 months ago
In Case You Missed It: Record monthly Canadian cannabis revenue takes top spot

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.   ICYMI Leade...

Stockhead GLH 5 months ago
10 at 11ish: First Au gets nod for bulk sampling at Victorian gold project

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead GLH 5 months ago
‘Current inventory moving very quickly’: Melodiol’s Canadian subsidiary continues to deliver record revenue

Mernova Medicinal has achieved its highest ever monthly revenue of nearly $900k in October Company has already received more than $600k of product orders for November providing a bumper start to the quarter ME1 reports ~$7.5 million in u...

Stockhead GLH 5 months ago
ASX October winners: The 50 best ASX stocks as Israel-Hamas escalation adds further pressure to fragile markets

The S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% for the month S&P ASX 200 Energy was the only sector that closed October in the black with all Australian equity factors in red Dimerix...

Stockhead GLH 5 months ago
In Case You Missed It: Quarterlies, a lithium takeover and a 1km long pegmatite body

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.   ICYMI Leade...

Stockhead GLH 5 months ago
Top 10 at 11: Graphite producer Greenwing Resources up 17pc after progress in Madagascar

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Stockhead GLH 5 months ago
Closing Bell: ASX unconvincing ahead of big CPI read and maiden address by new RBA boss

Benchmark ASX index closes ahead +0.19% Materials lead ASX sectors on Tuesday Small caps led by ERW, NMR   Local markets have struggled to hang onto early gains after a mixed run on Wall Street overnight. The benchmark ASX200 (XJO) index...

Stockhead GLH 5 months ago
Melodiol Global Health subsidiary posts 104pc revenue jump

Creso Pharma has changed its name to Melodiol Global Health (ASX:MEI) The cannabis-focused healthcare stock has seen a Canadian subsidiary post a 104 per cent increase in revenue vs Q3 CY22 The company reports it’s establishing a dom...

themarketherald.com.au GLH 5 months ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead GLH 5 months ago
ASX tumbles 0.35% as investors seek bonds and gold

On Monday, the Australian stock market experienced a decline as investors sought refuge in bonds and gold due to growing concerns about increasing tensions in the Middle East. At the closing bell, the S&P/ASX 200 was 0.35 per cent lower...

ShareCafe GLH 6 months ago
ASX Health Stocks: Global Health nabs Fujitsu contract, Althea generates $5.3m after property deal

Global Health announces deal with Fujitsu Australia Althea raises $5.32m in sale and leaseback deal Immutep to present data from TACTI-002 in key international forum   Global Health signs with Fujitsu Global Health (ASX:GLH), a provider o...

Stockhead GLH 6 months ago
ASX down 0.28% at noon as oil stabilises following Friday’s gains

Oil prices remained stable as Israel had not yet initiated its expected ground offensive in Gaza, while the United States intensified diplomatic efforts to prevent the crisis from escalating regionally. Brent crude traded near $91 per barre...

ShareCafe GLH 6 months ago
Stocks of the Hour: Tamboran Resources, Melodiol Global Health, Superior Resources

16 Oct 2023 - A snapshot of the stocks on the move, featuring Tamboran Resources (ASX:TBN), Melodiol Global Health (ASX:ME1, FRA:1X8) and Superior Resources (ASX:SPQ).

FNN GLH 6 months ago
Stocks of the Hour: Tamboran Resources, Melodiol Global Health, Superior Resources

  Tamboran Resources (ASX:TBN) announced that an operational update, in which the A3H well was drilled in record time of less than 18 days. In response, Managing Director and CEO, Joel Riddle, said, “the A3H well was drilled and cemented at...

ShareCafe GLH 6 months ago
In Case You Missed It: Green and brownfields gold exploration, and online marketplace boasts solid Q1

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.   ICYMI Leade...

Stockhead GLH 6 months ago
Melodiol says subsidiary Halucenex reports remission in 80 percent of first five patients in tri

Melodiol Global Health (ASX:ME1) has announced that its wholly-owned psychedelics subsidiary, Halucenex Life Sciences, has achieved encouraging preliminary results in the first five patients taking part in the phase 2 clinical trial...

BiotechDispatch GLH 6 months ago
In Case You Missed It: Abundant spodumene crystals and solid Q3 gold production

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today. ICYMI Leader...

Stockhead GLH 6 months ago
Record sales drive third straight quarter of revenue growth for Melodiol subsidiary Mernova

Record sales drives Mernova to deliver third consecutive quarter of revenue growth Sales up 20% on Q2 FY23 and 104% on pcp with Mernova YTD revenue of more than $4.95 million Mernova continues to build dominant footprint across Canada, wh...

Stockhead GLH 6 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead GLH 6 months ago
Sales highs continue for Melodiol as it grows its Mernova footprint right across Canada

Molodiol business Mernova achieves record sales for Q3 2023 Highest-ever weekly sales in Nova Scotia and $740,022 in purchase orders booked in for Q4 already Management pursuing a number of initiatives to replicate the growth in Nova Scoti...

Stockhead GLH 6 months ago
New Kidney Health Alliance Elevates Chronic Kidney Disease on Global Health Agenda

WASHINGTON, Sept. 20, 2023 /PRNewswire/ -- Seventeen patient advocacy organizations from North and South America, Europe, Asia and the Middle East have formed the Global Patient Alliance for Kidney Health. The Alliance aims to elevate pa...

Kalkine Media GLH 6 months ago
Kyrgyzstan, Ukraine, and Uzbekistan Update National Guidelines for Drug-Resistant TB Treatment to Advance National Rollout of Three-Drug, Six-Month Regimen

Interim results of operational research in LIFT-TB countries support decision to roll out improved treatment PRETORIA, South Africa, Sept. 19, 2023 /PRNewswire/ -- Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project —...

Kalkine Media GLH 6 months ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead GLH 7 months ago
In Case You Missed It: Construction materials player beats resources for top spot

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Stockhead GLH 7 months ago
Canadian cannabis drive: Melodiol subsidiary Mernova scores first purchase order from Alberta

Mernova secures first cannabis purchase order from Alberta Q3 revenues already breaking records with room for further growth Performance lays groundwork for strong second half in 2023   Melodiol Global Health (ASX:ME1) wholly-owned Canadi...

Stockhead GLH 7 months ago
Closing Bell: Liontown’s kitty is sitting pretty; Benchmark makes most of Monday ahead of RBA meet

  ASX 200 find 0.5% to start the week, LTR looks ready to sell Energy stocks and miners offset IT and Consumer Discretionary losses Small cap winners led by EMD and GLH   Local markets were led higher on Monday, supported by resource busi...

Stockhead GLH 7 months ago
Top 10 at 11: Emyria soars on funding news, and loads of tasty stuff unearthed in Canada.

Stockhead’s Top 10 at 11-ish, published once I’ve consumed enough coffee each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live (not frozen!) data. It’s a short, sharp update to help frame the tr...

Stockhead GLH 7 months ago
‘Extremely positive news’: Melodial welcomes US move to shift marijuana to less risky drug classification

Melodial Global Health welcomes moves to reschedule marijuana to a lower risk category in US Analyst says potential US policy change “could catalyse a significant re-rating of cannabis stocks” Melodial monitoring situation closely in even...

Stockhead GLH 7 months ago